Optimizing pediatric dosing: a developmental pharmacologic approach.

Abstract:

:Many physiologic differences between children and adults can result in age-related differences in pharmacokinetics. Understanding the effects of age on bioavailability, volume of distribution, protein binding, hepatic metabolic isoenzymes, and renal elimination can provide insight into optimizing doses for pediatric patients. We performed a search of English-language literature using the MEDLINE database regarding age and pharmacokinetics (1979-July 2008). We then evaluated the literature with an emphasis on drugs with one primary elimination pathway, such as renal clearance or a pathway involving a single metabolic isoenzyme. Our mechanistic-based analysis revealed that children need weight-corrected doses that are substantially higher than adult doses for drugs that are metabolically eliminated solely by the specific cytochrome P450 (CYP) isoenzymes CYP1A2, CYP2C9, and CYP3A4. In contrast, weight-corrected doses for drugs eliminated by renal excretion or metabolism involving CYP2C19, CYP2D6, N-acetyltransferase 2, or uridine diphosphate glucuronosyltransferases are similar in children and adults. In children, bioavailability of drugs with high first-pass metabolism is decreased for drugs metabolized by CYP1A2, CYP2C9, and CYP3A4. Limited data suggest that by age 5 years, bioavailability of drugs affected by efflux transporters should be equivalent to that of adults. Using a pharmacokinetics-based approach, rational predictions can be made for the effects of age on drugs that undergo similar pathways of elimination, even when specific pharmacokinetic data are limited or unavailable.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Anderson GD,Lynn AM

doi

10.1592/phco.29.6.680

subject

Has Abstract

pub_date

2009-06-01 00:00:00

pages

680-90

issue

6

eissn

0277-0008

issn

1875-9114

pii

10.1592/phco.29.6.680

journal_volume

29

pub_type

杂志文章,评审
  • Effects of carbamazepine on cyclosporine metabolism in pediatric renal transplant recipients.

    abstract::This study documents a pharmacokinetic interaction between carbamazepine and cyclosporine (CsA) in pediatric renal transplant recipients. Noncompartmental steady-state CsA pharmacokinetics were determined in three pediatric renal transplant recipients who were receiving both CsA and carbamazepine as long-term therapy ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Cooney GF,Mochon M,Kaiser B,Dunn SP,Goldsmith B

    更新日期:1995-05-01 00:00:00

  • TLR9 rs352139 Genetic Variant Promotes Tacrolimus Elimination in Chinese Liver Transplant Patients During the Early Posttransplantation Period.

    abstract:BACKGROUND:There are limited markers that could facilitate individualized tacrolimus treatment in the early posttransplantation period. Genetic factors have been found to play critical roles in determining tacrolimus pharmacokinetics. OBJECTIVE:We aimed to examine the association of donor and recipient Toll-like recep...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2204

    authors: Ou B,Liu Y,Zhang T,Sun Y,Chen J,Peng Z

    更新日期:2019-01-01 00:00:00

  • Aspirin for primary prevention of cardiovascular disease events.

    abstract::Aspirin has been used for the prevention and treatment of cardiovascular disease (CVD) for several decades. The efficacy of aspirin for secondary prevention of cardiovascular disease is well established, but the clinical benefit of aspirin for primary prevention of CVD is less clear. The primary literature suggests th...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1127

    authors: Nemerovski CW,Salinitri FD,Morbitzer KA,Moser LR

    更新日期:2012-11-01 00:00:00

  • Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.

    abstract::Bedaquiline is a diarylquinoline antitubercular drug with a novel mechanism of action against Mycobacterium tuberculosis. Bedaquiline works by inhibiting bacterial adenosine triphosphate (ATP) synthase and represents the first novel class of antituberculosis agents in more than 40 years. Bedaquiline is indicated for t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1482

    authors: Worley MV,Estrada SJ

    更新日期:2014-11-01 00:00:00

  • Ceftolozane/Tazobactam Pharmacokinetics in a Critically Ill Adult Receiving Continuous Renal Replacement Therapy.

    abstract::Limited data are available on ceftolozane/tazobactam dosing in patients receiving continuous renal replacement therapy (CRRT). Thus we performed a pharmacokinetic analysis of intravenous ceftolozane/tazobactam in a critically ill patient receiving CRRT at our medical center. A 47-year-old critically ill man with multi...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1744

    authors: Bremmer DN,Nicolau DP,Burcham P,Chunduri A,Shidham G,Bauer KA

    更新日期:2016-05-01 00:00:00

  • Effect of sustained endotoxemia on alpha1-adrenergic responsiveness in parenterally fed rats.

    abstract::We investigated the effect of endotoxemia on alpha1-adrenergic receptor-mediated smooth muscle contraction as measured by mean arterial pressure (MAP) in response to incremental doses of a vasopressor. Twelve male Sprague-Dawley rats were randomized to receive parenteral nutrition alone (PN) or in combination with a c...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Dickerson RN,Lima JJ,Kuhl DA,Brown RO,Hak LJ

    更新日期:1998-01-01 00:00:00

  • Drug absorption in gastrointestinal disease and surgery.

    abstract::It is well recognized that drug absorption from the gastrointestinal tract is influenced by gastric and intestinal motility, surface area available for absorption, and physicochemical properties of the drug. Disease and surgery have been shown to alter these factors. Consequently, drug absorption can be altered as wel...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1989.tb04140.x

    authors: Gubbins PO,Bertch KE

    更新日期:1989-01-01 00:00:00

  • Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia.

    abstract:STUDY OBJECTIVES:To compare the effectiveness of bivalirudin and argatroban in achieving anticoagulation goals and to compare clinical outcomes assessing the safety and efficacy in patients with known or suspected heparin-induced thrombocytopenia (HIT). DESIGN:Single-center, retrospective analysis. SETTING:Large tert...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.30.12.1229

    authors: Skrupky LP,Smith JR,Deal EN,Arnold H,Hollands JM,Martinez EJ,Micek ST

    更新日期:2010-12-01 00:00:00

  • Propafenone-theophylline interaction.

    abstract::A 63-year-old man with ventricular tachycardia (VT) refractory to drug therapy was admitted for surgical ablation of the VT with coronary artery bypass graft surgery. He developed increased theophylline concentrations with decreased calculated theophylline clearance after propafenone therapy for recurrent VT was initi...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Spinler SA,Gammaitoni A,Charland SL,Hurwitz J

    更新日期:1993-01-01 00:00:00

  • Mycobacterium szulgai in a patient with advanced acquired immunodeficiency syndrome: an unusual pathogen with unusual multidrug resistance.

    abstract::A 37-year-old Hispanic man with advanced acquired immunodeficiency syndrome developed extensive pulmonary disease with persistent cough, fever, night sweats, worsening dyspnea, and weight loss. Sputum samples showed scant growth of acid-fast bacilli. He failed to respond to the standard tuberculosis regimen of isoniaz...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.26.11.1646

    authors: Kang-Birken SL,Prichard JG

    更新日期:2006-11-01 00:00:00

  • Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination.

    abstract::Cytochrome P450 3A5 (CYP3A5) and cytochrome P450 3A4 (CYP3A4) are the predominate enzymes responsible for tacrolimus metabolism. The presence of CYP3A4 and CYP3A5 genetic variants significantly affects tacrolimus clearance and dose requirements. CYP3A5*3 is a loss-of-function variant resulting in no CYP3A5 enzyme prod...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.2131

    authors: Scheibner A,Remmel R,Schladt D,Oetting WS,Guan W,Wu B,Dorr C,Israni A,Jacobson PA

    更新日期:2018-07-01 00:00:00

  • Comparing the bispectral index and suppression ratio with burst suppression of the electroencephalogram during pentobarbital infusions in adult intensive care patients.

    abstract:OBJECTIVE:The bispectral index (BIS), a processed variable derived from the raw electroencephalogram (EEG) used to guide sedation in the intensive care unit (ICU), has not been tested during barbiturate therapy for elevated intracranial pressure. We determined the BIS and suppression ratio (SR) values during traditiona...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.10.1087.32766

    authors: Riker RR,Fraser GL,Wilkins ML

    更新日期:2003-09-01 00:00:00

  • Evaluation of serum creatinine concentration-based glomerular filtration rate equations in pediatric patients with chronic kidney disease.

    abstract:STUDY OBJECTIVE:To evaluate the accuracy of four equations based on serum creatinine concentration-the original Schwartz equation and the Leger, Bedside Chronic Kidney Disease in Children (CKiD), and Counahan-Barratt equations-for determining glomerular filtration rate (GFR) in pediatric patients with chronic kidney di...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/j.1875-9114.2012.01095.x

    authors: Lee CK,Swinford RD,Cerda RD,Portman RJ,Hwang W,Furth SL

    更新日期:2012-07-01 00:00:00

  • Cerivastatin-induced rhabdomyolysis: 11 case reports.

    abstract::3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors are a frequently prescribed class of drugs that are generally well tolerated by most patients. A rare, yet serious side effect associated with these drugs is rhabdomyolysis. Although all HMG-CoA reductase inhibitors can cause this adverse effect, pre...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.22.7.533.33674

    authors: Ravnan SL,Locke C,Yee WP,Haase K

    更新日期:2002-04-01 00:00:00

  • Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.

    abstract::Staphylococcus aureus (S. aureus) has proven to be a major pathogen with the emergence of methicillin-resistant S. aureus (MRSA) infections and recently with heteroresistant vancomycin-intermediate S. aureus (hVISA) and vancomycin-intermediate S. aureus (VISA) infections. Although vancomycin is traditionally a first-l...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1577

    authors: Gomes DM,Ward KE,LaPlante KL

    更新日期:2015-04-01 00:00:00

  • Reversible akinetic mutism possibly induced by baclofen.

    abstract::A 76-year-old man developed akinetic mutism after 3 days of receiving low-dosage baclofen. Electroencephalography showed a diffusely slow background with intermittent generalized sharp wave discharges. The condition resolved after discontinuing baclofen. To our knowledge, this is the first reported case of baclofen-in...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.19.6.468.31053

    authors: Rubin DI,So EL

    更新日期:1999-04-01 00:00:00

  • Vigabatrin for infantile spasms.

    abstract::Infantile spasms describe a pediatric epilepsy syndrome characterized by frequent clusters of brief symmetric muscle contractions; the condition is often associated with developmental delay. When infantile spasms are accompanied by hypsarrhythmia on electroencephalogram, the condition is labeled West syndrome. The mai...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.31.3.298

    authors: Pesaturo KA,Spooner LM,Belliveau P

    更新日期:2011-03-01 00:00:00

  • Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.

    abstract::Few patients presenting with acute ischemic stroke (AIS) are eligible for alteplase, especially those receiving ongoing anticoagulation. We describe the first reported case of a patient receiving full-dose intravenous (IV) alteplase for AIS after heparin reversal with protamine. A 73-year-old man presented with AIS. H...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.1997

    authors: Fontaine GV,Smith SM

    更新日期:2017-10-01 00:00:00

  • Evaluation of the half-life of intravenous human cytomegalovirus immune globulin in patients receiving partially mismatched related donor bone marrow transplantation.

    abstract:STUDY OBJECTIVE:To evaluate the pharmacokinetics and use of intravenous human cytomegalovirus immune globulin (CytoGam) in allogeneic bone marrow transplantation (BMT). DESIGN:Prospective, nonrandomized, nonblinded, single-center study. SETTING:University teaching hospital. PATIENTS:Five consecutive patients with he...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.15.1175.34592

    authors: DeRienzo SY,Chiang KY,O'Neal WM,Godder K,Abhyankar S,Christiansen NP,Bridges KD,Henslee-Downey PJ

    更新日期:2000-10-01 00:00:00

  • Anaphylactoid reaction to enoxaparin in a patient with deep venous thrombosis.

    abstract::A 40-year-old Caucasian man diagnosed with right deep venous thrombosis secondary to trauma was treated with subcutaneous enoxaparin. Within minutes of administering the first dose (1 mg/kg), he experienced an apparent anaphylactoid reaction; symptoms were abdominal pruritus, severe cough, shortness of breath, anxiety...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.16.1511.33688

    authors: MacLaughlin EJ,Fitzpatrick KT,Sbar E,Jewell C

    更新日期:2002-11-01 00:00:00

  • The pharmacologic activity of ketorolac tromethamine.

    abstract::Ketorolac tromethamine is a highly potent member of a class of compounds having both analgesic and antiinflammatory activity. In animal pain models using underlying inflammation, ketorolac markedly inhibited the pain response and increased the pain threshold; it did not exhibit any narcotic or central nervous system d...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Rooks WH 2nd

    更新日期:1990-01-01 00:00:00

  • Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy.

    abstract:OBJECTIVE:To identify and describe the scope of practice that characterizes the critical care pharmacist and critical care pharmacy services. Specifically, the goals were to define the level of clinical practice and specialized skills characterizing the critical care pharmacist as clinician, educator, researcher, and m...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors:

    更新日期:2000-11-01 00:00:00

  • Tacrolimus toxicity associated with concomitant metoclopramide therapy.

    abstract::Subtherapeutic tacrolimus trough concentrations were noted in a 52-year-old woman who had undergone liver transplantation. Her tacrolimus dosage was increased from 7 to 28 mg twice/day, and ketoconazole therapy was added; however, her tacrolimus concentration remained undetectable. Metoclopramide 10 mg 4 times/day was...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.24.5.532.33357

    authors: Prescott WA Jr,Callahan BL,Park JM

    更新日期:2004-04-01 00:00:00

  • Timing of Initiation of Oral Anticoagulation after Acute Ischemic Stroke in Patients with Atrial Fibrillation.

    abstract::Patients with atrial fibrillation (AF) who suffer an acute ischemic stroke are at risk for both hemorrhagic transformation and recurrent ischemic stroke in the acute post-stroke period. Oral anticoagulants are recommended for secondary stroke prevention in patients with AF. The optimal time to initiate anticoagulant t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2345

    authors: Smythe MA,Parker D,Garwood CL,Cuker A,Messé SR

    更新日期:2020-01-01 00:00:00

  • Antimicrobial formulary management: a case study in a teaching hospital.

    abstract::The role of the formulary system for effective cost containment is becoming increasingly important. With antimicrobial agents taking up a large proportion of most pharmaceutical budgets, this group of agents is an obvious target for cost reduction. The responsible interchange of selected antimicrobial agents offers a ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Wright DB

    更新日期:1991-01-01 00:00:00

  • Patient satisfaction with services provided by multidisciplinary anticoagulation clinics.

    abstract:STUDY OBJECTIVE:To assess patients' perception of care delivery by anticoagulation clinics (ACs) throughout Alberta, Canada. DESIGN:Prospective postal survey. SETTING:Therapy provision by an AC to ambulatory-based patients for a minimum of 3 months across the province. PATIENTS:A total of 1687 patients (67.9%) recei...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1002/phar.1318

    authors: Bungard TJ,Barry AR,Jones C,Brocklebank C

    更新日期:2013-11-01 00:00:00

  • Pharmacokinetics and dose-proportionality of oxymorphone extended release and its metabolites: results of a randomized crossover study.

    abstract:STUDY OBJECTIVE:To evaluate the pharmacokinetics and dose-proportionality of four dose strengths (5, 10, 20, and 40 mg) of oxymorphone extended release (ER) under both single-dose and steady-state conditions. DESIGN:Randomized, three-period, four-sequence, crossover study. SETTING:Bioavailability clinic. SUBJECTS:Tw...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.24.5.468.33347

    authors: Adams MP,Ahdieh H

    更新日期:2004-04-01 00:00:00

  • Physician-pharmacist collaborative management of asthma in primary care.

    abstract:OBJECTIVE:To determine if asthma control improves in patients who receive physician-pharmacist collaborative management (PPCM) during visits to primary care medical offices. DESIGN:Prospective pre-post study of patients who received the intervention in primary care offices for 9 months. The primary outcome was the sum...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1002/phar.1468

    authors: Gums TH,Carter BL,Milavetz G,Buys L,Rosenkrans K,Uribe L,Coffey C,MacLaughlin EJ,Young RB,Ables AZ,Patel-Shori N,Wisniewski A

    更新日期:2014-10-01 00:00:00

  • Decreased methadone effect after ritonavir initiation.

    abstract::Combination antiretroviral therapy including protease inhibitors such as ritonavir has added significant potency to therapy for human immunodeficiency viral (HIV) infection as well as substantial drug-drug interactions. Methadone metabolism is affected by cytochrome P450 (CYP) 3A4 inhibitors or inducers. Because riton...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.1.93.34654

    authors: Geletko SM,Erickson AD

    更新日期:2000-01-01 00:00:00

  • A case report of warfarin resistance due to azathioprine and review of the literature.

    abstract::A 32-year-old woman with a history of deep vein thrombosis (DVT), steroid-dependent ulcerative colitis, and osteoporosis was prescribed azathioprine for a steroid-sparing effect. Stable, therapeutic international normalized ratios (INRs) were obtained with warfarin 35 mg/week during a 6-week postpartum course to treat...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.21.3.355.34208

    authors: Havrda DE,Rathbun S,Scheid D

    更新日期:2001-03-01 00:00:00